Author

Pietro Bajona

The University of Texas Southwestern Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Christian LópeziD· 1 shared Damir AlzhanoviD· 1 shared Dian J. CaoiD· 1 shared Dinesh Ravindra RajuiD· 1 shared Elisabeth D. MartíneziD· 1 shared Eric N. OlsoniD· 1 shared Jinhua Wen· 1 shared Jun LiaoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Christian LópezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Histone lysine demethylase inhibition is a disease-modifying therapy for hypertrophic cardiomyopathy

Manjeet Singh, Yan Fan, Damir Alzhanov, Lingling Duan, Tram Ahn Tran, Dinesh Ravindra Raju, Jinhua Wen, Christian López, Matthias Peltz, Pietro Bajona, xing chao, Jun Liao, Dian J. Cao, Eric N. Olson, Elisabeth D. Martínez, Zhi‐Ping Liu

This study shows that inhibiting histone lysine demethylases with JIB-04 prevents and reverses hypertrophic cardiomyopathy through epigenetic changes.

bioRxiv · Aug 17, 2026 · PreprintPhysiology